Tech Company M&A Transactions

Boston Biomedical Acquisition

Boston Biomedical, based in Norwood, was bought by Dainippon Sumitomo Pharma. Dainippon Sumitomo Pharma said the transaction price was $2.6 billion.

Transaction Overview

Company Name
Announced On
3/2/2012
Transaction Type
M&A
Amount
$2,630,000,000
M&A Terms
DSP will acquire BBI for up to $2.63 billion in total which includes $200 million upfront, up to $540 million in development milestone payments, and up to $1.89 billion in sales milestone payments.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
333 Providence Hwy.
Norwood, MA 02062
USA
Email Address
Overview
Boston Biomedical, Inc. is a privately held biotechnology company focusing on research and development of novel therapeutics to treat cancer.
Profile
Boston Biomedical LinkedIn Company Profile
Social Media
Boston Biomedical Company Twitter Account
Company News
Boston Biomedical News
Facebook
Boston Biomedical on Facebook
YouTube
Boston Biomedical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Chiang Li
  Chiang Li LinkedIn Profile  Chiang Li Twitter Account  Chiang Li News  Chiang Li on Facebook
Chief Operating Officer
David Leggett
  David Leggett LinkedIn Profile  David Leggett Twitter Account  David Leggett News  David Leggett on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/2/2012: Silver Spring Networks venture capital transaction
Next: 3/2/2012: Canwe Studios venture capital transaction

 

Share this article

 


News on VC Transactions

Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary